August 19, 2009 (FinancialWire) — Generex Biotechnology Corp. (NASDAQ: GNBT) (www.generex.com), a leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a sales agreement with McCarthy and Sons Service (http://www.rafter8.ca/mccarthy-sons-service), a leading Canadian sales firm to veterinarians, pursuant to which McCarthy and Sons will promote sales of Glucose RapidSpray(tm) (www.glucoserapidspray.com), the company’s proprietary glucose spray product, on an exclusive representation basis to veterinarian clinics and veterinarian hospitals in the animal health industry in Canada.

For over 40 years, McCarthy and Sons has been servicing the Canadian veterinary community. McCarthy and Sons represents over 20 manufacturers and has a fully-integrated and experienced sales field staff that directly markets and details veterinarians throughout Canada. According to the Canadian Veterinary Medical Association, a national body representing and serving the interest of the veterinary profession Canada, as of 2009 there were 11,386 veterinarians and approximately 3,005 practices in Canada.

A Canadian survey done by Ipsos Reid estimated that there are 7.9 million cats and 5.9 million dogs in Canada and revealing that 35% of Canadian households have a dog, while 38% have a cat. In general, up to one in every 500 such pets eventually develops diabetes mellitus such that additional dietary glucose is or may be desirable. Glucose RapidSpray(tm) is designed to provide additional dietary glucose.

In addition, Glucose RapidSpray(tm) may be used to combat lethargy or first signs of low blood sugar often experienced by pet dogs or cats. Glucose RapidSpray(tm) can provide a user-friendly option for pet owners to react effectively to their pets’ needs. The liquid spray is absorbed by the inner lining of the mouth without any chewing or swallowing. Glucose (sugar) is the fuel that dogs and cats burn for energy and that is necessary for optimum functioning of brain and muscle tissues; without sufficient amounts of glucose, animals are weak and listless. Other potential uses include new born dogs and cats, toy breeds, hunting dogs, show dogs, pre-and-post operative care, aging pets, and pets with low appetites.

“Although originally designed for people seeking additional glucose in their diets, we are pleased that the product has additional applications in the animal health industry,” said Rose Perri, the company’s chief operating officer. “We extend credit to our Business Development and Marketing team for their ingenuity in seeking other viable markets for our product pipeline.”

Canadians spend $4 billion each year on their pets. The global animal health market was worth $17.4 billion in 2005 with a forecast annual compound growth rate of 4.5% to $21.7 billion in 2010. The United States accounts for 36% of the global market. The Pet Product Manufacturers Association estimates that United States consumers spent in excess of $40 billion on their pets in 2007 and Marketresearch.com has indicated that, during the period 1995 - 2005, pet spending tripled for households with incomes in excess of $70,000 and spending on convenience products grew 20% from 2005 to 2006 alone.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.